MedTrace Logo

Evaluation of Consumption of Sevoflurane in Chronic Obstructive Pulmonary Disease Patients

NCT06108973 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2023-10-31

No results posted yet for this study

Summary

All the Patients undergoing General Anesthesia and the patients who are having Chronic Obstructive Pulmonary Disease will be considered for this study. The Volume consumption of Sevoflurane will be studied in accordance with age, sex, duration , type of surgery, site of surgery and BMI.The volume consumption of sevoflurane is compared with Chronic Obstructive Pulmonary Disease and Normal Patients .

Conditions

Interventions

DEVICE

Capnography

To know the Co2 graph in COPD and Normal patients under General Anesthesia

Sponsors & Collaborators

  • Medtronic Spine LLC

    collaborator INDUSTRY

  • Employee's State Insurance Corporation, New Delhi

    lead OTHER_GOV

Principal Investigators

  • Dr Manjunath, MD · ESIC

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2024-12-30
Completion
2025-03-30
FDA Device
Yes

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06108973 on ClinicalTrials.gov